I. Udosen, “Protein Kinase C inhibitor Molecule Effect Partial Reversal of Spliceopathy in Myotonic Dystrophy Type 2 Cell Line: Journal of Natural Sciences Research, Vol.11, No.14”, ADI, pp. 17–22, Aug. 2020, doi: 10.60951/afrischolar-545.